SARS-CoV-2 Spike Proteins: A Key Target for COVID-19 Therapeutics Development

被引：0
|
作者：
Kohli, Khushi
Liu, Samuel
Garapaty, Arjun
机构：
来源：
FASEB JOURNAL | 2021年 / 35卷
关键词：
D O I：
10.1096/fasebj.2021.35.S1.04167
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development
    Guruprasad, Kunchur
    CURRENT RESEARCH IN STRUCTURAL BIOLOGY, 2022, 4 : 41 - 50
  • [2] Molecular characterization of COVID-19 therapeutics: luteolin as an allosteric modulator of the spike protein of SARS-CoV-2
    Alvarado, Walter
    Perez-Lemus, Gustavo R.
    Menendez, Cintia A.
    Bylehn, Fabian
    de Pablo, Juan J.
    MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2022, 7 (01): : 58 - 66
  • [3] Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
    Shailendra K. Saxena
    Swatantra Kumar
    Preeti Baxi
    Nishant Srivastava
    Bipin Puri
    R. K. Ratho
    VirusDisease, 2020, 31 (4) : 399 - 407
  • [4] A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics
    Lakhanpal, Amit
    Brahn, Ernest
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 : S102 - S106
  • [5] Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
    Chien, Minchen
    Anderson, Thomas K.
    Jockusch, Steffen
    Tao, Chuanjuan
    Li, Xiaoxu
    Kumar, Shiv
    Russo, James J.
    Kirchdoerfer, Robert N.
    Ju, Jingyue
    JOURNAL OF PROTEOME RESEARCH, 2020, 19 (11) : 4690 - 4697
  • [6] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [7] Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients
    Maghsood, Faezeh
    Shokri, Mohammad-Reza
    Jeddi-Tehrani, Mahmood
    Rahvar, Monireh Torabi
    Ghaderi, Abbas
    Salimi, Vahid
    Kardar, Gholam Ali
    Zarnani, Amir-Hassan
    Amiri, Mohammad Mehdi
    Shokri, Fazel
    PATHOGENS AND DISEASE, 2022, 80 (01):
  • [8] Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2
    Takamatsu, Akane
    Oshiro, Satoshi
    Mizutani, Naeko
    Tada, Tatsuya
    Tabe, Yoko
    Miida, Takashi
    Kirikae, Teruo
    Tagashira, Yasuaki
    VIRAL IMMUNOLOGY, 2022, 35 (03) : 254 - 258
  • [9] Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
    George, Santosh
    Pal, Anasuya Chattopadhyay
    Gagnon, Jacqueline
    Timalsina, Sushma
    Singh, Pallavi
    Vydyam, Pratap
    Munshi, Muhammad
    Chiu, Joy E.
    Renard, Isaline
    Harden, Christina A.
    Ott, Isabel M.
    Watkins, Anne E.
    Vogels, Chantal B. F.
    Lu, Peiwen
    Tokuyama, Maria
    Venkataraman, Arvind
    Casanovas-Massana, Arnau
    Wyllie, Anne L.
    Rao, Veena
    Campbell, Melissa
    Farhadian, Shelli F.
    Grubaugh, Nathan D.
    Dela Cruz, Charles S.
    Ko, Albert, I
    Perez, Amalia Z. Berna
    Akaho, Elikplim H.
    Moledina, Dennis G.
    Testani, Jeffrey
    John, Audrey R.
    Ledizet, Michel
    Ben Mamoun, Choukri
    KIDNEY360, 2021, 2 (06): : 924 - 936
  • [10] Role of cholesterol in COVID-19 disease and in the SARS-CoV-2 spike interaction
    Kocar, E.
    Skubic, C.
    Ivanusa, P.
    Brzin, J.
    Rezen, T.
    Turel, G.
    Bogovic, P.
    Strle, F.
    Rozman, D.
    FEBS OPEN BIO, 2021, 11 : 504 - 504
12345